Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where L Chisu is active.

Publication


Featured researches published by L Chisu.


Bioorganic & Medicinal Chemistry | 2008

Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis

Daniele Castagnolo; Alessandro De Logu; Marco Radi; Beatrice Bechi; Fabrizio Manetti; Matteo Magnani; Sibilla Supino; Rita Meleddu; L Chisu; Maurizio Botta

As a continuation of our previous work that turned toward the identification of antimycobacterial compounds with innovative structures, two series of pyrazole derivatives were synthesized by parallel solution-phase synthesis and were assayed as inhibitors of Mycobacterium tuberculosis (MTB), which is the causative agent of tuberculosis. One of these compounds showed high activity against MTB (MIC = 4 microg/mL). The newly synthesized pyrazoles were also computationally investigated to analyze their fit properties to the pharmacophoric model for antitubercular compounds previously built by us and to refine structure-activity relationship analysis.


Annals of Clinical Microbiology and Antimicrobials | 2007

Antiherpevirus activity of Artemisia arborescens essential oil and inhibition of lateral diffusion in Vero cells

M Saddi; Adriana Sanna; Filippo Cottiglia; L Chisu; Laura Casu; Leonardo Bonsignore; Alessandro De Logu

BackgroundNew prophylactic and therapeutic tools are needed for the treatment of herpes simplex virus infections. Several essential oils have shown to possess antiviral activity in vitro against a wide spectrum of viruses.AimThe present study was assess to investigate the activities of the essential oil obtained from leaves of Artemisia arborescens against HSV-1 and HSV-2MethodsThe cytotoxicity in Vero cells was evaluated by the MTT reduction method. The IC50 values were determined by plaque reduction assay. In order to characterize the mechanism of action, yield reduction assay, inhibition of plaque development assay, attachment assay, penetration assay and post-attachment virus neutralization assay were also performed.ResultsThe IC50 values, determined by plaque reduction assay, were 2.4 and 4.1 μg/ml for HSV-1 and HSV-2, respectively, while the cytotoxicity assay against Vero cells, as determined by the MTT reduction method, showed a CC50 value of 132 μg/ml, indicating a CC50/IC50 ratio of 55 for HSV-1 and 32.2 for HSV-2. The antiviral activity of A. arborescens essential oil is principally due to direct virucidal effects. A poor activity determined by yield reduction assay was observed against HSV-1 at higher concentrations when added to cultures of infected cells. No inhibition was observed by attachment assay, penetration assay and post-attachment virus neutralization assay. Furthermore, inhibition of plaque development assay showed that A. arborescens essential oil inhibits the lateral diffusion of both HSV-1 and HSV-2.ConclusionThis study demonstrates the antiviral activity of the essential oil in toto obtained from A. arborescens against HSV-1 and HSV-2. The mode of action of the essential oil as antiherpesvirus agent seems to be particularly interesting in consideration of its ability to inactivate the virus and to inhibit the cell-to-cell virus diffusion.


International Journal of Antimicrobial Agents | 2009

Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis.

Alessandro De Logu; Larisa H. Palchykovska; Valentina H. Kostina; Adriana Sanna; Rita Meleddu; L Chisu; Inna V. Alexeeva; Anatoly D. Shved

We investigated the in vitro activity of a new class of N-aryl and N-heteryl phenazine-1-carboxamide derivatives against Mycobacterium tuberculosis H37Rv and against drug-resistant ATCC M. tuberculosis strains. The activity against M. tuberculosis in J774 macrophage cells was also investigated. In most cases, minimum inhibitory concentrations (MICs) ranging between 0.19 mg/L and 0.79 mg/L were found, and comparable MIC values were obtained against 26 susceptible and 5 drug-resistant clinical isolates. Several derivatives were shown to be effective in inhibiting the growth both of susceptible and resistant strains at comparable concentrations. Results obtained indicate that these compounds could represent a promising class of agents useful for the treatment of M. tuberculosis infections caused by drug-resistant strains.


35° Congresso della Società Italiana di Microbiologia (SIM). | 2007

L’olio essenziale di Artemisia arborescens inattiva HSV-1 e HSV-2 e inibisce la diffusione laterale in cellule Vero

M Saddi; Rita Meleddu; Adriana Sanna; L Chisu; Alessandro De Logu


3° Congresso Nazionale della Società Italiana di Microbiologia Farmaceutica (SIMiF). | 2006

Aumento della sensibilità all’AmB di biofilm di Candida albicans fluconazolo-resistente nell’impiego combinato con derivati ciclici isotiosemicarbazonici

M Saddi; M. C. Cardia; L Chisu; R Borgna; Elias Maccioni; B Saddi; Alessandro De Logu


3° CONGRESSO NAZIONALE DELLA SOCIETÀ ITALIANA DI MICROBIOLOGIA FARMACEUTICA (S.I.M.I.F.) | 2006

Attività intramacrofagica di nuovi agenti antitubercolari per il trattamento delle infezioni sostenute da ceppi MDR mediante inibizione selettiva della RNA polimerasi.

M Saddi; Lh Palchykovska; L Chisu; Vh Kostina; Ts Shestakova; Alexeeva; B Saddi; Ad Shved; Alessandro De Logu


3° CONGRESSO NAZIONALE DELLA SOCIETÀ ITALIANA DI MICROBIOLOGIA FARMACEUTICA (S.I.M.I.F.) | 2006

Studio della attività di una nuova classe di isotiosemicarbazoni nei confronti di Aspergillus spp. di isolamento clinico.

L Chisu; M. C. Cardia; M Saddi; B Saddi; Elias Maccioni; Alessandro De Logu


34° Congresso della Società Italiana di Microbiologia (SIM). | 2006

Attività di un derivato isotiosemicarbazonico ciclico nei confronti di biofilm di Candida albicans FLC-S e FLC-R in combinazione con AMB

M Saddi; L Chisu; M. C. Cardia; B Saddi; Elias Maccioni; Alessandro De Logu


XXXIV Congresso Nazionale della Associazione Microbiologi Clinici Italiani | 2005

Derivati fenazinici come potenziali agenti per il trattamento delle infezioni sostenute da M. tuberculosis resistenti e multiresistenti

M Saddi; Li Palchykovska; R Borgna; Vg Kostina; L Chisu; A. Soru; Ts Shestakova; S. Magnapane; Inna V. Alexeeva; B Saddi; Anatoly D. Shved; A. De Logu


XXXIV Congresso Nazionale della Associazione Microbiologi Clinici Italiani | 2005

STUDIO DELL’ATTIVITÀ DI ANALOGHI CICLICI ISOTIOSEMICARBAZONICI NEI CONFRONTI DI ISOLATI CLINICI DI ASPERGILLUS SPP.

L Chisu; M. C. Cardia; R Borgna; M Saddi; S. Magnapane; A. Soru; D. Cabitza; D. Maccioni; B Saddi; Elias Maccioni; A. De Logu

Collaboration


Dive into the L Chisu's collaboration.

Top Co-Authors

Avatar

M Saddi

University of Cagliari

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

R Borgna

University of Cagliari

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anatoly D. Shved

National Academy of Sciences of Ukraine

View shared research outputs
Top Co-Authors

Avatar

Inna V. Alexeeva

National Academy of Sciences of Ukraine

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge